Thank you.
Good morning, Ms. Boscoe and Mr. Carleton. We are happy that you are here today. You have raised an important issue about the number of women and children participating in clinical trials.
I would like to talk about a vaccine that has caused a number of deaths. I am referring to Gardasil, which is used for the human papilloma virus. To date, it has caused 11 deaths in Europe and in the United States.
I would like to hear your views on this situation. How do you think Canada can be more proactive in providing the public with information? You are undoubtedly aware of what happened, are you not? Did the parents receive any information? Very few girls between the ages of nine and 15 participated in the clinical trials. Apparently, there were 1,200 girls, compared to 20,000 women from the female population in general. What would you like to see? We hear that there have been deaths and serious consequences. It is more than an adverse effect when people die, it is the limit of what is acceptable. How can a government be more proactive with respect to tragic situations like death?